NCT05516563

Brief Summary

Gluteal tendinopathy, a degenerative condition of the gluteal tendons, is a common cause of lateral hip pain. It is three times more common in women, affecting up to 25% of those aged over 40 years. Research evidence supporting the most effective interventions remains limited. A 2018 landmark three-arm RCT (LEAP trial) in Australia compared EDucation on load management plus eXercise (EDX) against corticosteroid injection (CSI), and a 'wait-and see' control on pain and global improvement in 205 individuals with gluteal tendinopathy (Mellor et al, 2016; 2018). Results showed superior and significant positive effects in the EDX group, compared with CSI and wait-and-see groups at 8 weeks and 1 year. A total of 14 EDX sessions was provided over 8 weeks in LEAP, but in the public healthcare system in Ireland, typically 5-6 physiotherapy treatments are provided. Therefore, whilst the LEAP trial demonstrated positive effects for EDX, implementation into clinical practice in Ireland is questionable as 6 or less treatment sessions are typically provided in public and private settings in Ireland (French et al, 2020). This two-arm feasibility RCT aims to evaluate the feasibility of conducting a future RCT of a reduced dose (6 sessions) of a recently proven efficacious physiotherapy treatment of EDucation plus eXercise (EDX-Ireland) to usual care for gluteal tendinopathy in an Irish setting. A Study Within A Trial will evaluate if exercise adherence is improved with use of a smartphone app compared with paper-based diaries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

August 25, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

March 27, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2025

Completed
Last Updated

January 20, 2026

Status Verified

May 1, 2024

Enrollment Period

1.7 years

First QC Date

July 27, 2022

Last Update Submit

January 15, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Success of different patient recruitment methods (including community recruitment, primary care and secondary care)

    Number of participants recruited using different recruitment methods, and the number retained at the 8-week and 3-month time-points will be recorded.

    Through study completion, an average of 1 year

  • Usual care treatment/recommendations for Gluteal Tendinopathy in Ireland

    The constituents of care received from the referral source (GP, orthopedics, rheumatologists, musculoskeletal triage physiotherapists) for Gluteal Tendinopathy in Ireland will be assessed at baseline for all those allocated to the usual care arm

    Through study completion, an average of 1 year

  • Cost-effectiveness information of Gluteal Tendinopathy in Ireland

    Healthcare costs change from baseline, at 8 weeks and 3 months (including pain medication usage, GP visits, investigations, attendance at physiotherapy/other healthcare practitioners or hospital attendance) by trial participants for their hip pain will be recorded.

    Baseline, 8 weeks and 3 months

Secondary Outcomes (10)

  • Pain severity - Numeric Pain Rating scale (NPRS)

    baseline, and at 8weeks, and 3months

  • VISA Gluteal (VISA-G)

    baseline, and at 8weeks, and 3months

  • Patient-Specific Functional Scale (PSFS)

    baseline, and at 8weeks, and 3months

  • Patient Health Questionnaire-9 (PHG-9)

    Baseline, 8 weeks and 3 months

  • The EuroQol 5-D-5L

    Baseline, 8 weeks and 3 months

  • +5 more secondary outcomes

Study Arms (2)

EDucation and eXercise intervention (EDX)

ACTIVE COMPARATOR

EDX-Ireland will involve 6 face-to-face education and exercise sessions on a individualised basis with a physiotherapist, delivered over eight weeks. This will be supplemented by a home based exercise programme.

Other: EDucation and eXercise intervention

Usual Care

NO INTERVENTION

Participants will continue to follow what they have done so far for their hip pain, or what their doctor has suggested/prescribed. If a participant is referred to physiotherapy as part of the usual care treatment, waiting time will be recorded. Participants will receive a written information leaflet on the pathology of gluteal tendinopathy and general advice on symptom management.

Interventions

The exercise programme includes 3 key streams: 1. Low-load isometric abduction 2. Functional loading 3. Abductor loading: Graduated abductor loading, designed to improve load tolerance by applying progressively higher loads across the abductor muscles. Daily exercise will be completed three days a week at a 'hard' to 'very hard' level, alternating with three 'light' days and one rest day. The clinic day will constitute one of the 'hard' days. Education will be delivered via a 20 minute video which focusses on understanding and managing lateral hip pain ( ie pain associated with gluteal tendinopathy). Education will also be tailored to each patient on attendance with the physiotherapist at the 6 clinic visits

EDucation and eXercise intervention (EDX)

Eligibility Criteria

Age35 Years - 70 Years
Sexall(Gender-based eligibility)
Gender Eligibility Details3:1
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 35-70 years
  • Lateral hip pain for at least 3 months, of ≥ 4/10 on an 11-point numeric rating scale on most days of the last 3 months
  • Tenderness on palpation of the greater trochanter
  • Reproduction of pain on at least one of following diagnostic clinical tests: (FADER test, FADER with Static muscle test (internal rotation) at end of range (FADER-R), FABER test, passive hip Adduction in side lying (ADD) test, adduction with resisted isometric abduction (ADD-R), and single leg stand (SLS) for 30 seconds
  • Demonstrated tendon pathology on MRI
  • Access to a computer, smartphone or tablet with internet connection

You may not qualify if:

  • Previous cortisone injection in the region of the lateral hip in the last 12 months
  • Physiotherapy (including regular appropriate Pilates) for lateral hip pain in the last 3 months
  • Lumbar spine or lower limb surgery in the last 6 months
  • Any known advanced hip joint pathology where groin pain is the primary complaint and/or where groin pain is experienced at an average intensity of ≥2 on most days of the week, or Kellgren-Lawrence score of \>2 (mild) on X-Ray
  • If the following clinical criteria for the diagnosis of hip osteoarthritis (American College Rheumatology) are fulfilled:
  • Self-reported hip pain with either hip internal rotation \<15° and hip flexion ≤115° or ≥15° hip internal rotation and pain on hip internal rotation
  • Μorning stiffness ≤ 60 minutes
  • Αge ≥ 50 years
  • Hip joint flexion is \<90°, bilaterally
  • Lumbar radiculopathy or pain in another body location that is greater than the hip pain (NRS)
  • Known advanced knee pathology or restricted knee range of motion (must have minimum 90° flexion and full extension, bilaterally)
  • Any systemic diseases affecting the muscular or nervous system, and uncontrolled diabetes
  • Fibromyalgia
  • Use of cane or walking aid
  • Malignant tumour (current or in the past 6 months)
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RCSI

Dublin, Dublin, D02 YN77, Ireland

Location

Related Publications (4)

  • French HP, Woodley SJ, Fearon A, O'Connor L, Grimaldi A. Physiotherapy management of greater trochanteric pain syndrome (GTPS): an international survey of current physiotherapy practice. Physiotherapy. 2020 Dec;109:111-120. doi: 10.1016/j.physio.2019.05.002. Epub 2019 Jun 2.

    PMID: 31493863BACKGROUND
  • Mellor R, Bennell K, Grimaldi A, Nicolson P, Kasza J, Hodges P, Wajswelner H, Vicenzino B. Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial. BMJ. 2018 May 2;361:k1662. doi: 10.1136/bmj.k1662.

    PMID: 29720374BACKGROUND
  • Mellor R, Grimaldi A, Wajswelner H, Hodges P, Abbott JH, Bennell K, Vicenzino B. Exercise and load modification versus corticosteroid injection versus 'wait and see' for persistent gluteus medius/minimus tendinopathy (the LEAP trial): a protocol for a randomised clinical trial. BMC Musculoskelet Disord. 2016 Apr 30;17:196. doi: 10.1186/s12891-016-1043-6.

    PMID: 27139495BACKGROUND
  • Almousa S, Vicenzino B, Mellor R, Grimaldi A, Bennett K, Doyle F, McCarthy GM, McDonough SM, Ryan JM, Lynch K, Sorensen J, French HP. An EDucation and eXercise intervention for gluteal tendinopathy in an Irish setting: a protocol for a feasibility randomised clinical trial (LEAP-Ireland RCT). HRB Open Res. 2024 Jun 28;6:76. doi: 10.12688/hrbopenres.13796.2. eCollection 2023.

MeSH Terms

Interventions

Educational Status

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A feasibility randomised controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2022

First Posted

August 25, 2022

Study Start

March 27, 2023

Primary Completion

December 20, 2024

Study Completion

January 30, 2025

Last Updated

January 20, 2026

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Locations